-
Mashup Score: 0Next Generation Complement Therapeutics Market – Know the Untapped Revenue Growth Opportunities - 5 month(s) ago
Next Generation Complement Therapeutics Market worth $23.04 Bn by 2031 – Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Next-Generation Complement Therapeutics Market Size, Share & Trends Analysis Report By Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Paroxysmal Nocturnal Hemoglobinuria, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barr
Source: www.digitaljournal.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0
A new Report by Worldwide Market Reports, titled “Healthcare Patient Experience Tracking Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030,” offers a comprehensive analysis of the industry, which comprises insights on the Healthcare Patient Experience Tracking market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful
Source: www.digitaljournal.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 2Clene (NASDAQ: CLNN) Reports Improved Survival Status in ALS Patients Treated with CNM-Au8(R) on Follow-Up Analysis - 6 month(s) ago
Clene is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases like ALS In 2019, Clene’s dr ug candidate, CNM-Au8(R), was selected for the HEALEY ALS Platform Trial, with enrollment commencing in the summer of 2020 Over the years since, Clene has consistently released additional data from the Trial, most recently reporting significant long-term survival improvement among patients treated with CNM-Au8
Source: www.digitaljournal.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 0Clene (NASDAQ: CLNN) Applies Patented Nanotechnology to Development of CNM-Au8(R), its Investigational Drug for ALS - 7 month(s) ago
In line with recent emphasis on the growing importance of nanotechnology in the US, Clene Nanomedicine innovated its investigational drug, CNM-Au8(R), using nanotechnology for the treatment of neurodegene rative disease Clene’s nanotechnological approach was recently recognized by the NINDS of NIH with a substantial grant to conduct an Expanded Access Protocol in ALS with CNM-Au8(R) Clene aims to file a New Drug Application for CNM-Au8(R) for ALS indications in the first half of 2024 October 2023 has
Source: www.digitaljournal.comCategories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 0
The Digital Therapeutics Market is at the forefront of healthcare innovation, offering a paradigm shift in the way medical conditions are managed and treated. These software-driven interventions harness the power of technology, combining evidence-based therapies with personalized, data-driven approaches to improve patient outcomes. From mental health and chronic disease management to addiction recovery and sleep disorders, digital therapeutics are proving to be effective, sc alable, and accessible
Source: www.digitaljournal.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
The latest competent intelligence report published by WMR with the title “An Increase in Demand and Opportunities for Global Mental Health Digital Therapeutics Market 2023 ″ provides a sorted image of the Mental Health Digital Therapeutics industry by analysis of research and information collected from various sources that have the ability to help the decision-makers in the worldwide market to play a significant role in making a gradual impact on the global economy. The report presents and showcases a
Source: www.digitaljournal.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
In recent years, the world has witnessed a digital revolution that has transformed various industries, and healthcare is no exception. The digital health market, an amalgamation of technology and healthcare, has emerged as a disruptive force that is revolutionizing the way medical services are delivered and accessed. This rapidly evolving field encompasses a wide range of technologies, applications, and services that leverage the power of data, artificial intelligence, mobile devices, wearables, and the
Source: www.digitaljournal.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Healthcare Revolution | Wearable Devices Market Soars as Chronic Disease Prevalence Drives Demand - 10 month(s) ago
The global Wearable Healthcare Devices Market Size is expected to grow from US$ 16 billion in 2021 to US$ 30 billion by 2026. Furthermore, between 2022 and 2032, global demand for Wearable Healthcare Devices is predicted to expand at a 13% CAGR, reaching nearly US$ 61 billion by the end of 2032. The rising prevalence of chronic diseases, advancements in wearable medical devices, rising health awareness among people, and the increasing need for patients to keep track of vital parameters are some of the
Source: www.digitaljournal.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0New Trends of Digital Health Evidence Market To Receive Overwhelming Hike In Revenue That Will Boost Overall Industry Growth,Forecast 2030 - 11 month(s) ago
“Worldwide Market Reports offers a 70% discount on Digital Health Evidence Market Reports on Single User Access and Unlimited User Access“ The latest research study released by Worldwide Market Reports on “Digital Health Evidence Market” with 100+ pages of analysis on business strategy taken up by emerging industry players, geographical scope, market segments, product landscape and price, and…
Source: www.digitaljournal.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
PRESS RELEASEPublished June 6, 2023The Influential APOE Gene: Heart Health, Brain Function, and Alzheimer’s Unraveling the APOE gene’s power guides informed health choices. APOE’s significance in heart health, cognitive function, and Alzheimer’s risk aids in devising personalized prevention strategies and early detection measures. Genetic testing empowers individuals to manage their health…
Source: www.digitaljournal.comCategories: Expert Picks, Latest HeadlinesTweet
Next Generation Complement Therapeutics Market – Know the Untapped Revenue Growth Opportunities https://t.co/GYCsa08U6d https://t.co/0mziYZXzJ9